Evidence map›Paper›PMID 26335255›Full record

ArticleInternational journal of cancer2016

Metabolic activation of 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine and DNA adduct formation depends on p53: Studies in Trp53(+/+),Trp53(+/-) and Trp53(-/-) mice.

Annette M Krais, Ewoud N Speksnijder, Joost P M Melis, Rajinder Singh, Anna Caldwell, Gonçalo Gamboa da Costa, Mirjam Luijten, David H Phillips, Volker M Arlt

Open access · hybridAbstract read
In one paragraph

Article in International journal of cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. The Impact of p53 on Aristolochic Acid I-Induced Gene Expression In Vivo.International journal of molecular sciences · 2019
    Article
  10. Article
  11. Article
  12. Article
  13. Chemical Analysis of DNA Damage.Analytical chemistry · 2018
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 4 countries.

Annette M KraisAnalytical and Environmental Sciences Division, MRC-PHE Centre for Environment and Health, King's College London, London, SE1 9NH, United Kingdom.
Ewoud N SpeksnijderCenter for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven, MA, 3721, The Netherlands.
Joost P M MelisCenter for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven, MA, 3721, The Netherlands.
Rajinder SinghDepartment of Cancer Studies and Molecular Medicine, University of Leicester, Leicester, LE2 7LX, United Kingdom.
Anna CaldwellMass Spectrometry Facility, King's College London, London, SE1 9NH, United Kingdom.
Gonçalo Gamboa da CostaDivision of Biochemical Toxicology, National Center for Toxicological Research, Jefferson, AR, 72079.
Mirjam LuijtenCenter for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven, MA, 3721, The Netherlands.
David H PhillipsAnalytical and Environmental Sciences Division, MRC-PHE Centre for Environment and Health, King's College London, London, SE1 9NH, United Kingdom.
Volker M ArltAnalytical and Environmental Sciences Division, MRC-PHE Centre for Environment and Health, King's College London, London, SE1 9NH, United Kingdom.
King's College London · GBNational Institute for Public Health and the Environment · NLLeiden University Medical Center · NLLund University · SENational Center for Toxicological Research · USUniversity of Leicester · GB

Funding

Cancer Research UK 14329Cancer Research UK C313/A14329Wellcome Trust 101126/B/13/ZWellcome Trust 101126/Z/13/Z
6 · The paper itself

Abstract

The expression of the tumor suppressor p53 can influence the bioactivation of, and DNA damage induced by, the environmental carcinogen benzo[a]pyrene, indicating a role for p53 in its cytochrome P450 (CYP)-mediated biotransformation. The carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), which is formed during the cooking of food, is also metabolically activated by CYP enzymes, particularly CYP1A2. We investigated the potential role of p53 in PhIP metabolism in vivo by treating Trp53(+/+), Trp53(+/-) and Trp53(-/-) mice with a single oral dose of 50 mg/kg body weight PhIP. N-(Deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP-C8-dG) levels in DNA, measured by liquid chromatography-tandem mass spectrometry, were significantly lower in liver, colon, forestomach and glandular stomach of Trp53(-/-) mice compared to Trp53(+/+) mice. Lower PhIP-DNA adduct levels in the livers of Trp53(-/-) mice correlated with lower Cyp1a2 enzyme activity (measured by methoxyresorufin-O-demethylase activity) in these animals. Interestingly, PhIP-DNA adduct levels were significantly higher in kidney and bladder of Trp53(-/-) mice compared to Trp53(+/+) mice, which was accompanied by higher sulfotransferase (Sult) 1a1 protein levels and increased Sult1a1 enzyme activity (measured by 2-naphthylsulfate formation from 2-naphthol) in kidneys of these animals. Our study demonstrates a role for p53 in the metabolism of PhIP in vivo, extending previous results on a novel role for p53 in xenobiotic metabolism. Our results also indicate that the impact of p53 on PhIP biotransformation is tissue-dependent and that in addition to Cyp1a enzymes, Sult1a1 can contribute to PhIP-DNA adduct formation.

Indexed as

Activation, MetabolicAnimalsBlotting, WesternCarcinogensChromatography, LiquidDNA AdductsImidazolesMaleMiceMice, Inbred C57BLMice, KnockoutTandem Mass SpectrometryTumor Suppressor Protein p532-amino-1-methyl-6-phenylimidazo(4,5-b)pyridineCarcinogensDNA AdductsImidazolesTumor Suppressor Protein p53carcinogen metabolismcytochrome P450DNA adduct formationheterocyclic aromatic hydrocarbonmass spectrometrymouse modelPhIPsulfotransferasestumor suppressor p53

Identifiers

PMID26335255
PMCPMC4832306
OpenAlexW2136467031

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.